|
Conventional Neuroleptics
Citations 1-10 of 98 total displayed.
|
Most recent content
(1 Nov 2007):
|
- Treatment in Psychiatry
Chronic Restlessness With Antipsychotics
- Irene M. Bratti, John M. Kane, and Stephen R. Marder
Am J Psychiatry 2007; 164: 1648-1654.
[Full text]
[PDF]
|
Past content
(since Dec 1998):
|
- Articles
Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications
- Helen C. Kales, Marcia Valenstein, H. Myra Kim, John F. McCarthy, Dara Ganoczy, Francesca Cunningham, and Frederic C. Blow
Am J Psychiatry 2007; 164: 1568-1576.
[Abstract]
[Full text]
[PDF]
- Articles
Social Cognition and Neurocognition: Effects of Risperidone, Olanzapine, and Haloperidol
- Mark J. Sergi, Michael F. Green, Clifford Widmark, Christopher Reist, Stephen Erhart, David L. Braff, Kimmy S. Kee, Stephen R. Marder, and Jim Mintz
Am J Psychiatry 2007; 164: 1585-1592.
[Abstract]
[Full text]
[PDF]
- Articles
Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial
- Joo-Cheol Shim, Jae-Goo K. Shin, Deanna L. Kelly, Do-Un Jung, Young-Soo Seo, Kwang-Hyeon Liu, Ji-Hong Shon, and Robert R. Conley
Am J Psychiatry 2007; 164: 1404-1410.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Drs. Stroup, Rosenheck, Essock, and Lieberman Reply
- T. SCOTT STROUP, ROBERT A. ROSENHECK, SUSAN E. ESSOCK, and JEFFREY A. LIEBERMAN
Am J Psychiatry 2007; 164: 1266-a-1267-a.
[Full text]
[PDF]
- Letters to the Editor
Pretrial Medication Bias in Randomized Antipsychotic Drug Trials
- STEFAN LEUCHT, STEPHAN HERES, JOHANNES HAMANN, and WERNER KISSLING
Am J Psychiatry 2007; 164: 1266.
[Full text]
[PDF]
- Treatment in Psychiatry
Neuroleptic Malignant Syndrome
- Jeffrey R. Strawn, Paul E. Keck, Jr., and Stanley N. Caroff
Am J Psychiatry 2007; 164: 870-876.
[Full text]
[PDF]
- Editorials
Lessons From Each Drug Trial
- Stephen R. Marder
Am J Psychiatry 2007; 164: 375-376.
[Full text]
[PDF]
- Articles
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine: A CATIE Study
- T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, Marvin S. Swartz, Sonia M. Davis, George A. Capuano, Robert A. Rosenheck, Richard S.E. Keefe, Alexander L. Miller, Irving Belz, John K. Hsiao,, for the CATIE Investigators
Am J Psychiatry 2007; 164: 415-427.
[Abstract]
[Full text]
[PDF]
- Reviews and Overviews
Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic Use
- Daniel Polsky, Jalpa A. Doshi, Mark S. Bauer, and Henry A. Glick
Am J Psychiatry 2006; 163: 2047-2056.
[Abstract]
[Full text]
[PDF]
|
|
